Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits
- 30 November 2002
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 43 (6) , 999-1005
- https://doi.org/10.1016/s0028-3908(02)00176-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The prevalence of depression in Alzheimer's disease and vascular dementia in a population sampleJournal of Affective Disorders, 1999
- Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouseEuropean Journal of Pharmacology, 1999
- Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's diseaseAmerican Journal of Psychiatry, 1996
- Effects of moclobemide on forced-swimming stress and brain monoamine levels in micePharmacology Biochemistry and Behavior, 1996
- Drug Choice in DepressionCNS Drugs, 1995
- RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE INHIBITION OF MONOAMINE OXIDASE TYPES A AND B IN THE RAT VAS DEFERENSBritish Journal of Pharmacology, 1982
- TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE BBritish Journal of Pharmacology, 1981
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- Hypertensive Interactions Between Monoamine Oxidase Inhibitors and FoodstuffsThe British Journal of Psychiatry, 1967
- INTERACTIONS OF CHEESE AND OF ITS CONSTITUENTS WITH MONOAMINE OXIDASE INHIBITORSBritish Journal of Pharmacology and Chemotherapy, 1966